These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7997564)

  • 41. MR Imaging in Monitoring and Predicting Treatment Response in Multiple Sclerosis.
    Río J; Auger C; Rovira À
    Neuroimaging Clin N Am; 2017 May; 27(2):277-287. PubMed ID: 28391786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insights from Ultrahigh Field Imaging in Multiple Sclerosis.
    Schindler MK; Sati P; Reich DS
    Neuroimaging Clin N Am; 2017 May; 27(2):357-366. PubMed ID: 28391792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Magnetic resonance imaging of the brain and spine. Is clinical efficacy established after the first decade?
    Kent DL; Larson EB
    Ann Intern Med; 1988 Mar; 108(3):402-24. PubMed ID: 3277514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of field strength on image quality in MRI.
    Rutt BK; Lee DH
    J Magn Reson Imaging; 1996; 6(1):57-62. PubMed ID: 8851404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Magnetic resonance imaging characteristics of multiple sclerosis plaques imaged with two-dimensional and three-dimensional Fourier transform techniques at low and mid field strengths.
    Rothschild PA; Kramer DM; Schulz M; Kaufman L
    J Neuroimaging; 1991 May; 1(2):79-84. PubMed ID: 10149805
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ultra-high-field MR imaging in multiple sclerosis.
    Filippi M; Evangelou N; Kangarlu A; Inglese M; Mainero C; Horsfield MA; Rocca MA
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):60-6. PubMed ID: 23813636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review.
    Whiting P; Harbord R; Main C; Deeks JJ; Filippini G; Egger M; Sterne JA
    BMJ; 2006 Apr; 332(7546):875-84. PubMed ID: 16565096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Field strength in neuro-MR imaging: a comparison of 0.5 T and 1.5 T.
    Jack CR; Berquist TH; Miller GM; Forbes GS; Gray JE; Morin RL; Ilstrup DM
    J Comput Assist Tomogr; 1990; 14(4):505-13. PubMed ID: 2370347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MR imaging in multiple sclerosis: review and recommendations for current practice.
    Lövblad KO; Anzalone N; Dörfler A; Essig M; Hurwitz B; Kappos L; Lee SK; Filippi M
    AJNR Am J Neuroradiol; 2010 Jun; 31(6):983-9. PubMed ID: 20019103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physics of thin-section MR imaging at low field strength.
    Kramer DM; Guzman RJ; Carlson JW; Crooks LE; Kaufman L
    Radiology; 1989 Nov; 173(2):541-4. PubMed ID: 2798887
    [TBL] [Abstract][Full Text] [Related]  

  • 51. McArdle Sign: A Specific Sign of Multiple Sclerosis.
    Savoldi F; Nasr Z; Hu W; Schilaty ND; Delgado AM; Mandrekar J; Kaufman KR; Berglund L; Weinshenker BG
    Mayo Clin Proc; 2019 Aug; 94(8):1427-1435. PubMed ID: 31303427
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A systematic review of the utility of 1.5 versus 3 Tesla magnetic resonance brain imaging in clinical practice and research.
    Wardlaw JM; Brindle W; Casado AM; Shuler K; Henderson M; Thomas B; Macfarlane J; Muñoz Maniega S; Lymer K; Morris Z; Pernet C; Nailon W; Ahearn T; Mumuni AN; Mugruza C; McLean J; Chakirova G; Tao YT; Simpson J; Stanfield AC; Johnston H; Parikh J; Royle NA; De Wilde J; Bastin ME; Weir N; Farrall A; Valdes Hernandez MC;
    Eur Radiol; 2012 Nov; 22(11):2295-303. PubMed ID: 22684343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low field strength magnetic resonance imaging of the neonatal brain.
    Whitby EH; Paley MN; Smith MF; Sprigg A; Woodhouse N; Griffiths PD
    Arch Dis Child Fetal Neonatal Ed; 2003 May; 88(3):F203-8. PubMed ID: 12719393
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting assessments of magnetic resonance imaging in suspected multiple sclerosis.
    Mooney C; Mushlin AI; Phelps CE
    Med Decis Making; 1990; 10(2):77-94. PubMed ID: 2112217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Half-Fourier MR imaging of CNS disease.
    Runge VM; Wood ML
    AJNR Am J Neuroradiol; 1990; 11(1):77-82. PubMed ID: 2105620
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantification of multiple sclerosis lesion volumes in 1.5 and 0.5 T anisotropically filtered and unfiltered MR exams.
    Mitchell JR; Karlik SJ; Lee DH; Eliasziw M; Rice GP; Fenster A
    Med Phys; 1996 Jan; 23(1):115-26. PubMed ID: 8700022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple sclerosis: should MR criteria for dissemination in time be less stringent.
    Polman CH; Wolinsky JS; Reingold SC
    Ann Neurol; 2004 Feb; 55(2):297. PubMed ID: 14755738
    [No Abstract]   [Full Text] [Related]  

  • 58. Results of a prospective multicenter study for evaluation of the diagnostic quality of an open whole-body low-field MRI unit. A comparison with high-field MRI measured by the applicable gold standard.
    Merl T; Scholz M; Gerhardt P; Langer M; Laubenberger J; Weiss HD; Gehl HB; Wolf KJ; Ohnesorge I
    Eur J Radiol; 1999 Apr; 30(1):43-53. PubMed ID: 10389012
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Venezuelan consensus guidelines on the use of magnetic resonance in diagnosis and follow up of patients with multiple sclerosis].
    Lander B; Alvarado M; Alvarez IC; Armas E; Chique-Alfonzo G; Hernandez F; Labarca R; Leon R; Molina O; Monasterios I; Ramirez CI; Rubio E; Torres B; Viso-Barroso R; Simmonds Z; Soto A
    Rev Neurol; 2017 Aug; 65(3):117-126. PubMed ID: 28699154
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation between MR and clinical findings of disease activity in multiple sclerosis.
    McFarland HF
    AJNR Am J Neuroradiol; 1999; 20(10):1777-8. PubMed ID: 10588096
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.